FDA Reevaluates Estrogen Black Box Warning: A Milestone for Menopausal Health?
On July 17, 2025, the FDA convened a panel of experts to reevaluate the role of estrogen in menopausal hormone therapy (MHT). Physicians and researchers gathered to discuss the latest evidence around the safety and efficacy of estrogen therapy—especially in light of long-standing concerns that have shaped treatment decisions for over two decades. One possible—and […]
FDA Reevaluates Estrogen Black Box Warning: A Milestone for Menopausal Health? Read More »